NUOC Northwest 2026 | BONUS Official

ONCO X 2026

NATIONAL UNDERGRADUATE ONCOLOGY CONFERENCE

NORTHWEST

|

ONCO X 2026 builds on the success of Moonshot 2025, exploring often overlooked areas of cancer care from early life to end of life. With added emphasis on paediatric and palliative perspectives, the conference brings together student societies across specialties allied with oncology including surgery, radiology, and pathology fostering collaboration and dialogue across the multidisciplinary team.

From Early Life to End of Life; Exploring the Unexplored

INFORMATION TO FOLLOW

Registration has not yet opened.

All those interested in presenting abstracts at the conference are invited to submit their work to the Committee for review. Any submissions will be anonymized prior to receipt by the committee and scored according to relevance, originality, scientific content, overall clarity and impact. The highest scoring abstracts will be invited to give a 5-minute presentation to the congress; all other submissions will be offered to present as a poster. There will be a prize for the winning presentation, and certificates for all presenters. This conference is run by students, for students; please only submit if you are still within your university studies (this includes intercalating students). We welcome relevant submissions from students across all components of the Oncology MDT; Medicine, Dentistry, Nursing, Physiotherapy, Occupational Therapy, Radiology, etc. Unfortunately we will not be accepting submissions from MB-PhD students.

Abstract instructions: Maximum word count: 350 words. Any submissions in excess will automatically be rejected.

Abstract submission has not yet opened.

Where is it?

Liverpool Guild of Students

Who can attend?

The conference is primarily aimed at medical students of all years, but is open to attend by all undergraduate students, recent graduates and doctors.

A ticket (£6) will give you access to the full day of events, including keynote lectures from cancer experts across the region, interactive workshops to explore various aspects of the Oncology multi-disciplinary team, research poster sessions, and networking opportunities. This ticket includes lunch.

£1 from all ticket sales will be a direct donation to Northwest Cancer Research, who we are happy to be supporting through this conference

Why Onco X?

The name Onco X was derived from Cancer X, the follow-up to the Project Moonshot initiative. Moonshot was the name of the American government's

initiative and goal to propel progress in cancer research and reduce cancer deaths by 50% through fostering collaboration amongst scientists, doctors and patients globally.

EDIT THIS PAGE

Registration	Foyer, Samuel Alexander Building	8:30 AM
Welcome address	Lecture Hall, Samuel Alexander Building	9:00 AM
Maggie's Centres - Charity talk	Lecture Hall, Samuel Alexander Building	9:10 AM
Dr David Eaton - Advancements in Systemic Breast Cancer Treatments	Lecture Hall, Samuel Alexander Building	9:20 AM
Prof. Arthur Sun Myint - Advocacy in Radiotherapy: Should Patients Have a Choice?	Lecture Hall, Samuel Alexander Building	10:05 AM
BMA - Sponsor talk	Lecture Hall, Samuel Alexander Building	10:45 AM
Morning Break	Foyer	10:55 AM
Workshops - Session 1	Classrooms	11:15 AM
Flash talks (Research posters)	Lecture Hall, Samuel Alexander Building	12:00 PM
Lunch	Students' Union Building	12:30PM
Poster session	Classrooms	1:30 PM
Prof. Andrew Wardley - Global Perspectives in Bridging Cancer Care Gaps	Lecture Hall, Samuel Alexander Building	2:15 PM
Dr Jonathan Lim - The Cancer Immunotherapy Revolution	Lecture Hall, Samuel Alexander Building	3:00 PM
Manchester Cancer Research Centre - Sponsor Talk	Lecture Hall, Samuel Alexander Building	3:40 PM
Afternoon Break	Foyer	3:50 PM
Workshops - Session 2	Classrooms	4:10 PM
Prof Ann Henry - Why You Should Become an Academic Clinical Oncologist	Lecture Hall, Samuel Alexander Building	5:00 PM
Closing remarks & Awards	Lecture Hall, Samuel Alexander Building	5:40 PM
Participant departure	End of conference	6:00 PM

EDIT EDIT EDIT

Dr Jonathan Lim

Consultant Medical Oncologist, The Christie NHS Foundation Trust

The Cancer Immunotherapy Revolution

Dr Jonathan Lim is a clinical senior lecturer and honorary consultant medical oncologist in advanced immunotherapy and cell therapy for solid cancers at The University of Manchester and The Christie NHS Foundation Trust. He is passionate about translational research and in developing novel advanced therapies, especially in the settings of early-phase clinical trials and first-in-human studies. He actively serves as a member of the ESMO Translational Research Faculty, the ESMO Resilience Task Force, and is an Associate Editor of the ESMO IOTECH journal. He is an alumnus of the ESMO Leaders Generation Programme.

Professor Andrew Wardley

Consultant Medical Oncologist, The Christie NHS Foundation Trust

Global Perspectives in Addressing Gaps in Cancer Care

Professor Andrew Wardley is an internationally-renowned consultant medical oncologist and breast cancer specialist with practice across the UK with Sciensus (Healthcare at Home). His expertise in breast cancer research, innovation and transformation has enabled him to ensure that the multiple international clinical trials he has led throughout his career, have been adopted in clinical practice to improve the outcomes and the experience of people with breast cancer. He is the current chair of the Association of Cancer Physicians and co-founded Manchester Breast Centre and helped to design and develop Manchester Cancer Research Centre.

Advancements in Systemic Breast Cancer Therapies

Dr David Eaton is a consultant medical oncologist at the University Hospitals of Morecambe Bay NHS Trust with an interest in Breast Cancer and Acute Oncology. His work specialises in the systemic treatment of breast cancer, from early to late stages, including the role of new and innovative systemic therapies in improving care for patients.

Dr David Eaton

Consultant Medical Oncologist, Morecambe Bay NHS Foundation Trust

Professor Arthur Sun Myint

Consultant Clinical Oncologist, The Clatterbridge Cancer Centre

Should Patients Have a Choice?: Advancing Radiotherapy Techniques

Prof Sun Myint introduced contact radiotherapy for the treatment of rectal cancer to the UK, establishing the Papillon unit at Clatterbridge in 1993. He has served on the Council of Association of Coloproctology of Great Britain and Ireland and the Royal College of Radiologists. He was elected president of International Contact Radiotherapy Society in 2013. In 2018 the Papillon team, led by Prof Sun Myint, won the prestigious BMJ Cancer Care team of the Year award. In 2021, Prof Sun Myint received a lifetime award for his contributions in advancing radiotherapy in Europe.

Professor Ann Henry

Consultant Clinical Oncologist, Leeds NHS Foundation Trust

Why Become an Academic Clinical Oncologist

Prof Ann Henry is an Associate Professor in Clinical Oncology at the University of Leeds. She specialises in the radiation treatment of urological cancers and was appointed as a clinical academic in 2014. Her research aims to optimise radiation treatments to improve overall survival and reduce treatment related side effects. She is co-investigator on a number of multi-centre CRUK funded radiotherapy clinical trials and Leeds Co-Investigator on CRUK funded Advanced Radiotherapy Technologies Network. She is the brachytherapy expert on the EAU (European Association of Urologists) Prostate Cancer Guidelines group and the NHSE Radiotherapy Clinical Reference Group.

EDIT THIS PAGE

Building a Standout Medical Portfolio: Your Path to Success!

Are you unsure how to build a strong medical portfolio that sets you apart? Wondering what really matters when applying for jobs or opportunities? Join us for an interactive and engaging workshop designed to help medical students craft a compelling portfolio that highlights their strengths, achievements, and aspirations. Pao is the current Technology lead for the British Oncology Network of Undergraduate Societies (BONUS) and the Early Career Researchers in Cancer (UK ECRC). With his experience in Oncology and building a national network throughout medical school and post-graduate training, Pao will be able to provide valuable insights and guidance.

Dr Thitikorn Nuamek (Pao)

Clinical Research Fellow, The Christie NHS Foundation Trust

Interventional Oncology: Where Radiology Meets Cancer Care

Dr Zhong is a clinical academic and Cancer Research UK Clinical Trial Fellow in Interventional Oncology working in the Leeds Institute of Medical Research and Leeds CRUK Clinical Trials Unit. His work involves studying the effects of combining image-guided ablative modalities with immunotherapy in liver and kidney cancer to improve patient outcomes. He is also an Honorary Consultant Radiologist specialising in Interventional Oncology and performs tumour ablation in solid organs tumours of the lung, liver and kidneys.

Dr Jim Zhong

Clinical Research fellow, Leeds NHS Foundation Trust

Dr Amy Gadoud & Dr Amara Nwosu

Marie Curie Hospice, Lancaster Medical School

Palliative Care in Oncology

This is a joint workshop with Dr Amy Gadoud and Dr Amara Nwosu. They will explore the role of palliative medicine in the cancer care pathway.

Amy Gadoud is a Senior Lecturer in Palliative Medicine at Lancaster Medical School where she is NIHR Integrated Clinical Academic Training Lead. She works with colleagues in the International Observatory on End of Life Care, Lancaster University. Her main research interest is ensuring equality in access to palliative care using a range of research methods from analysing large datasets to qualitative studies.

Dr Amara Nwosu is a Senior Clinical Lecturer in Palliative Care at Lancaster Medical School. He is also the Research lead for Marie Curie Hospice Liverpool and a former Research Scholar for the National Institute for Health Research (NIHR) North West Coast Clinical Research Network (CRN)). Clinically, I am an Honorary Consultant in Palliative Care at the Royal Liverpool University Hospitals NHS Foundation Trust.

Artificial Intelligence and Digital Pathology in Oncology

Dr Xu Xuan Lim is an FY1 doctor at Lancashire Teaching Hospitals, and an honorary clinical research fellow at the Christie NHS Hospital. He has an interest in Pathology and has a wide range of experiences in academic research. This workshop will focus on digital pathology, working with AI, and the importance of inter-specialty collaboration in cancer care.

Dr Xu Xuan Lim

Honorary Research Fellow, FY1

The Christie NHS Hospital

Gynaecological Malignancies: Diagnosis and Management

Dr Adishesh is a consultant gynae-oncology surgeon in Lancashire, with a wide experience in research and treatment for gynaecological cancers. This workshop will focus on the management of gynaecological cancers, including a range of case-based discussions to introduce participants to the patient-pathway.

Dr Meera Adishesh

Consultant in Gynae-Oncology, Lancashire Teaching Hospitals

Mr Michael Brockdorff

PhD Candidate, The University of Leeds

Dr Mariam Obeid

Registrar in Oncology, The Christie NHS Hospital

Dr Charlotte Nixon

Clinical Research Fellow, The Christie NHS Hospital

Soft Magnetic Surgical Robots in Cancer-related Applications

Michael is current PhD candidate with STORM Lab at the University of Leeds, where he is reading for a PhD in Medical Robotics. Michael is a member of Robotics at Leeds post-graduate Network. He has undertaken internships at the University of Tokyo and University of Malta, developing his research portfolio and expertise in embedded systems programming and compressive sensing for ghost imaging applications. He completed an MSc at Imperial College London in 2020, focused on neurotechnology. Soft robots are increasingly common due to their inherent safety when interacting with people and their potential to be fabricated at a low cost. Michael’s team are exploring pneumatic, hydraulic and magnetic soft robots to provide minimally invasive access to specific surgical sites. Website: https://www.stormlabuk.com/

Managing Brain Metastases: SRS (Stereotactic Radiosurgery)

Dr. Mariam Obeid is a Clinical Oncology Registrar at The Christie NHS Foundation Trust in Manchester. She is the former Co-Chair of the Royal College of Radiologists’ (RCR) Oncology Registrar Forum (ORF) and has contributed as a representative on multiple RCR committees. With a strong commitment to advancing cancer care, she is particularly passionate about the role of radiotherapy in curative treatment, striving to improve outcomes and innovation in oncology. This workshop will explore the presentation, management, and complexities of brain metastases, with a special focus on Stereotactic Radiosurgery (SRS)—a highly precise, non-invasive radiation therapy that delivers targeted high-dose radiation to brain metastases while sparing surrounding healthy tissue. In addition to the discussion, this session will include a practical demonstration on how to contour and plan an SRS case.

Systemic Approaches to Managing Metastatic Bladder Cancer

Dr. Charlotte Nixon is a Clinical Research Fellow with both the Experimental Cancer Medicine Team (ECMT) and the Urology Research Team at The Christie Hospital. Her work with ECMT focuses on early phase clinical trials for all solid organ tumour types while the trials she works on with the Urology Team focus on those with urological malignancy and are typically in the later phases of research. This workshop will follow a fictionalised patient from their original diagnosis with localised disease through to their metastatic diagnosis and their referral to the clinical trials team. The workshop will highlight the latest advancements in systemic therapies for metastatic bladder cancer and the ongoing research into novel treatments including targeted therapies.

Radiotherapy Planning: Bladder Cancer

Dr Saad is a senior clinical fellow doing a fellowship in advanced radiotherapy techniques. Their research focuses on implementing advanced radiotherapy techniques to improve cancer outcomes and patient experience with radiotherapy. This workshop will introduce participants to the concept and techniques behind planning radiotherapy. Ever wondered how oncologists target radiation to the tumour, while avoiding dosing healthy organs? Learn about dosimetry, types of radiation beams and avoiding high risk organs to reduce side effects. This workshop is perfect for the budding clinical oncologist.

Dr Ereny Saad

Registrar in Oncology, The Christie NHS Hospital

Arrival

EDIT THIS

Getting there

Parking

Travel and Transport Costs

As this is a student-led conference, unfortunately, we are unable to provide any financial support to participants in regards to travel, transport and accommodation.

Lunch

Participants Networking Group - BONUS App

We are happy to be collaborating with BONUS (British Oncology Network of Undergraduate Societies) in delivering the NUOC website. We have also created a section on the BONUS mobile app, and a group discussion page for participants to network before and after the conference. Information to join this group will be communicated to participants.

A NORTHWEST COLLABORATION

NUOC Northwest is an inter-university collaboration between the student oncology societies of The University of Manchester (Preston), The University of Leeds, University of Central Lancashire, University of Liverpool and Lancaster University - led by medical students, for students.

THANK YOU TO OUR SPONSORS

CONTACT US

nuocnorthwest

National Undergradatue Oncology Conference | Northwest

In Partnership with British Oncology Network for Undergraduate Societies